Back

Reduction of mitral regurgitation in patients with heart failure and secondary mitral regurgitation: relationship between changes in brain natriuretic peptide and outcomes from the COAPT trial

1 September 2019 (11:54 - 12:12)
Organised by:
Congress Presentation Part of: From trials to clinical use: transcatheter interventions in secondary mitral regurgitation Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Gregg Stone

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

4 More presentations in this session

Presentation thumbnail
State of the Art - Review of current evidence for transcatheter interventions in secondary mitral regurgitation
Professor S. Kapadia (Cleveland, US)
Slides Video
Presentation thumbnail
MitraClip treatment of functional mitral regurgitation - A meta-analysis
Assistant Professor M. Noutsias (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Combined tricuspid and mitral vs. isolated mitral valve repair for severe mitral and tricuspid regurgitation: An analysis from TriValve and TRAMI registries
Mr M. Mehr (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Surgical vs. catheter-based treatment of mitral regurgitation in 2030
Professor F. Maisano (Milan, IT)
Video

Access the full session

Session thumbnail
From trials to clinical use: transcatheter interventions in secondary mitral regurgitation

The Event

Event poster

ESC Congress 2019

1 September 2019 11:54 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources